Profile data is unavailable for this security.
About the company
Exscientia PLC is a United Kingdom-based artificial intelligence (AI)-driven precision medicine company. It is focused on discovering, designing and developing the possible drugs. It has developed the functional precision oncology platform to guide treatment selection and improve patient outcomes in a prospective interventional clinical study, as well as to progress AI-designed small molecules into the clinical setting. Its internal pipeline is focused on leveraging its precision medicine platform in oncology, while its partnered pipeline broadens its approach to other therapeutic areas. Its patient-first AI platform includes Precision Target, Precision Design, Precision Experiment, Precision Medicine, Presentations and Publications. Its Precision Target combines genetic data and global literature in machine learning models to anticipate and confirm disease-target associations. Its advanced biophysical and x-ray techniques provide the ideal experimental underpinnings for AI-design.
- Revenue in USD (TTM)25.02m
- Net income in USD-181.89m
- Incorporated2021
- Employees483.00
- LocationExscientia PLCThe Schrodinger BuildingOxford Science ParkOXFORD OX4 4GEUnited KingdomGBR
- Phone+44 186 581 8941
- Websitehttps://www.exscientia.ai/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adlai Nortye Ltd (ADR) | 0.00 | -62.74m | 500.00m | 129.00 | -- | -- | -- | -- | -1.68 | -1.68 | 0.00 | -6.83 | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -100.00 | -- | -3.73 | -- | -- | -- |
| Altimmune Inc | 426.00k | -88.45m | 501.94m | 59.00 | -- | 2.58 | -- | 1,178.26 | -1.64 | -1.64 | 0.008 | 2.75 | 0.002 | -- | 0.6636 | 7,220.34 | -42.36 | -39.62 | -45.55 | -42.58 | -- | -- | -20,762.21 | -1,811.89 | -- | -- | 0.00 | -- | 726.47 | -47.15 | -4.41 | -- | -45.92 | -- |
| Alector Inc | 97.06m | -130.39m | 502.68m | 244.00 | -- | 3.32 | -- | 5.18 | -1.56 | -1.56 | 1.16 | 1.58 | 0.1377 | -- | 75.04 | 397,795.10 | -18.50 | -20.00 | -22.92 | -23.81 | -- | -- | -134.34 | -124.07 | -- | -- | 0.00 | -- | -27.36 | 28.52 | 2.19 | -- | 4.79 | -- |
| Nkarta Inc | 0.00 | -117.50m | 503.27m | 150.00 | -- | 1.29 | -- | -- | -2.40 | -2.40 | 0.00 | 5.56 | 0.00 | -- | -- | 0.00 | -27.59 | -32.39 | -29.14 | -34.05 | -- | -- | -- | -372,519.20 | -- | -- | 0.00 | -- | -- | -- | -3.22 | -- | 106.05 | -- |
| Phibro Animal Health Corp | 982.01m | 14.80m | 508.73m | 1.92k | 34.38 | 1.88 | 10.25 | 0.518 | 0.3654 | 0.3654 | 24.24 | 6.69 | 1.02 | 2.37 | 6.49 | 511,465.60 | 1.53 | 5.46 | 1.87 | 6.83 | 30.43 | 31.41 | 1.51 | 5.11 | 1.60 | 2.50 | 0.6369 | 42.99 | 3.78 | 3.59 | -33.69 | -13.56 | 22.80 | 3.71 |
| Absci Corp | 5.72m | -110.57m | 510.91m | 155.00 | -- | 2.39 | -- | 89.35 | -1.20 | -1.20 | 0.0621 | 1.89 | 0.0212 | -- | 3.06 | 36,890.32 | -41.08 | -- | -46.22 | -- | -- | -- | -1,933.65 | -- | -- | -93.25 | 0.0467 | -- | -0.5046 | -- | -5.40 | -- | -- | -- |
| Arrivent Biopharma Inc | 0.00 | -69.33m | 512.45m | 40.00 | -- | -- | -- | -- | -2.17 | -2.17 | 0.00 | 4.73 | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -87.86 | -- | -- | -- |
| AnaptysBio Inc | 17.16m | -163.62m | 515.72m | 117.00 | -- | 5.82 | -- | 30.06 | -6.07 | -6.07 | 0.6372 | 3.31 | 0.0323 | -- | 4.15 | 146,641.00 | -30.79 | -18.08 | -32.75 | -18.96 | -- | -- | -953.66 | -269.21 | -- | -- | 0.00 | -- | 66.78 | 27.97 | -27.11 | -- | -5.36 | -- |
| Celcuity Inc | 0.00 | -63.78m | 515.88m | 55.00 | -- | 3.09 | -- | -- | -2.70 | -2.70 | 0.00 | 5.48 | 0.00 | -- | -- | 0.00 | -34.76 | -37.32 | -36.88 | -39.16 | -- | -- | -- | -- | -- | -- | 0.2095 | -- | -- | -- | -57.99 | -- | -31.12 | -- |
| Allogene Therapeutics Inc | 95.00k | -327.27m | 519.00m | 232.00 | -- | 1.00 | -- | 5,463.14 | -2.09 | -2.09 | 0.0006 | 3.04 | 0.0001 | -- | -- | 409.48 | -44.70 | -28.46 | -47.65 | -30.21 | -- | -- | -344,489.50 | -1,123.44 | -- | -- | 0.00 | -- | -39.10 | -- | 3.86 | -- | -14.06 | -- |
| Exscientia PLC (ADR) | 25.02m | -181.89m | 520.87m | 483.00 | -- | 1.17 | -- | 20.82 | -1.45 | -1.45 | 0.199 | 3.53 | 0.0346 | 1,096.08 | 9.86 | 51,802.40 | -25.16 | -- | -29.09 | -- | -36.47 | -- | -726.94 | -- | 6.22 | -- | 0.0505 | -- | -26.24 | -- | -22.94 | -- | -- | -- |
| SNDL Inc | 663.51m | -122.72m | 520.98m | 2.52k | -- | 0.594 | -- | 0.7852 | -0.4711 | -0.4838 | 2.56 | 3.37 | 0.5995 | 5.29 | 36.58 | 263,715.40 | -11.34 | -24.44 | -12.28 | -27.94 | 24.17 | 22.49 | -18.92 | -62.17 | 2.69 | -9.29 | 0.1196 | -- | 27.63 | -- | 49.83 | -- | -- | -- |
| Phathom Pharmaceuticals Inc | 682.00k | -201.59m | 533.74m | 452.00 | -- | -- | -- | 782.61 | -3.89 | -3.89 | 0.0133 | -1.26 | 0.0024 | -- | -- | 1,508.85 | -69.68 | -83.26 | -78.50 | -93.77 | 75.51 | -- | -29,558.94 | -135,982.00 | 10.22 | -4.91 | 1.20 | -- | -- | -- | -1.96 | -- | -- | -- |
| OmniAB Inc | 34.16m | -50.62m | 534.09m | 106.00 | -- | 1.69 | -- | 15.63 | -0.4986 | -0.4986 | 0.3292 | 2.69 | 0.0858 | -- | 2.00 | 322,301.90 | -12.71 | -- | -13.55 | -- | -- | -- | -148.16 | -- | -- | -- | 0.00 | -- | -42.17 | -- | -126.65 | -- | -- | -- |
| ORIC Pharmaceuticals Inc | 0.00 | -100.70m | 544.40m | 100.00 | -- | 1.98 | -- | -- | -1.97 | -1.97 | 0.00 | 4.08 | 0.00 | -- | -- | 0.00 | -40.34 | -33.92 | -43.47 | -35.77 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -12.99 | -- | 10.09 | -- |
Data as of Apr 25 2024. Currency figures normalised to Exscientia PLC's reporting currency: US Dollar USD
17.77%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Laurion Capital Management LPas of 31 Dec 2023 | 5.41m | 4.29% |
| Baillie Gifford & Co.as of 31 Dec 2023 | 4.69m | 3.72% |
| Platinum Investment Management Ltd.as of 31 Dec 2023 | 4.09m | 3.24% |
| Woodline Partners LPas of 31 Dec 2023 | 1.64m | 1.30% |
| Bill & Melinda Gates Foundation Trust (Investment Management)as of 31 Dec 2023 | 1.59m | 1.26% |
| MIC Capital Management UK LLPas of 31 Dec 2023 | 1.54m | 1.22% |
| Marshall Wace LLPas of 31 Dec 2023 | 1.30m | 1.03% |
| Irish Life Investment Managers Ltd.as of 04 Apr 2024 | 1.19m | 0.94% |
| BlackRock Fund Advisorsas of 31 Dec 2023 | 628.66k | 0.50% |
| Millennium Management LLCas of 31 Dec 2023 | 334.72k | 0.27% |
More ▼
Data from 31 Dec 2023 - 18 Apr 2024Source: FactSet Research Systems Inc.
